WEIGHTED MONEY
UAE’s Globalpharma targets market for generic Ozempic
Globalpharma has more than doubled sales since 2019 and expects revenues to triple this year, with projections exceeding $150 million
Marcus Brandt/ dpa- Via Getty Images
A customs investigator holds a package of Ozempic
Share 
Globalpharma is preparing to manufacture generic versions of blockbuster weight-loss drugs like Ozempic and Mounjaro.
The Dubai Investments subsidiary is partnering internationally to develop peptide-based injectables using off-patent precursors, aligning with national goals to localise pharmaceutical production.
“The...